Chronic Pancreatitis clinical trials

Explore recruiting chronic pancreatitis clinical trials.

Recruiting chronic pancreatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Pancreatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled trial.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Tocilizumab for Painful Chronic Pancreatitis: A Randomised, Placebo-controlled, Double-blinded, Investigator-initiated Trial (TOPAC trial)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis: a multicenter randomized placebo-controlled, double-blinded clinical trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Diagnostic yield of Endoscopic aspiration of duodenopancreatic juice after secretin stimulation (ADPJ-secr-) vs endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for molecular analysis of intraductal papillary mucinous intraductal neoplasia (IPMN)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Pancreatitis trials by city

Chronic Pancreatitis in Toronto Chronic Pancreatitis in Vancouver Chronic Pancreatitis in Montreal Chronic Pancreatitis in Calgary Chronic Pancreatitis in Edmonton Chronic Pancreatitis in Ottawa Chronic Pancreatitis in Winnipeg Chronic Pancreatitis in Quebec City Chronic Pancreatitis in Hamilton Chronic Pancreatitis in Kitchener Chronic Pancreatitis in London Chronic Pancreatitis in Halifax Chronic Pancreatitis in New York Chronic Pancreatitis in Los Angeles Chronic Pancreatitis in Chicago Chronic Pancreatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease